Key takeaways

• No single marker defines a T cell subset — identity comes from combinations, which is why panel design matters more than any individual antibody.
• CD3 gates the T cell population; CD4 and CD8 then split it into helper and cytotoxic lineages.
• CD45RA and CD45RO are reciprocal isoforms distinguishing naive from memory cells, and CD62L further separates central from effector memory.
• CD69 marks very early activation, CD25 later activation, and HLA-DR sustained activation — so activation markers report timing, not just status.
• Regulatory T cells require intracellular FOXP3 staining alongside surface CD25, which means a fixation and permeabilisation step.
• Gamma delta T cells are identified by their TCR rather than by CD4 or CD8, and are easily missed in panels built only around alpha beta cells.
• Immunophenotyping underpins leukaemia and lymphoma classification, immunodeficiency workup, vaccine immunogenicity studies and CAR-T monitoring.

Contents

• What are T lymphocytes?
• What is immunophenotyping?
• Immunophenotyping by flow cytometry
• T cell subsets and their markers
• Helper T cell subsets
• Designing a T cell panel
• Applications
• Immunophenotyping in T cell immunodeficiency
• Choosing flow antibodies
• Frequently asked questions

Antibodies for T cell immunophenotyping

A workable T cell panel starts with a pan-T gate, adds the lineage split, then layers on differentiation and regulatory markers. The products below cover that core.

CD3

APC Anti-Human CD3 Antibody [OKT-3]

APC conjugateHuman

The pan-T cell marker used to gate the T cell population before any subsetting.

View product →

CD4

PE Anti-Human CD4 Antibody [RPA-T4]

PE conjugateHuman

Identifies helper T cells; the MHC class II co-receptor.

View product →

CD8a

Purified Anti-Human CD8a Antibody [OKT-8]

Purified mAbHuman

Identifies cytotoxic T cells; the MHC class I co-receptor.

View product →

CD45RA

PE Anti-Human CD45RA Antibody [HI100]

PE conjugateHuman

Distinguishes naive from memory cells — reciprocal to CD45RO expression.

View product →

CD25

CD25 / IL2RA Rabbit Polyclonal Antibody

Rabbit pAbHuman

Activation marker, and part of the regulatory T cell signature alongside FOXP3.

View product →

FOXP3

FOXP3 Rabbit Monoclonal Antibody

Rabbit mAbHuman

The regulatory T cell transcription factor — intracellular, so requires permeabilisation.

View product →

What are T lymphocytes?

T lymphocytes are a class of white blood cell central to adaptive immunity. They arise in the bone marrow and mature in the thymus, which is where the T in their name comes from, and each carries a T cell receptor of unique specificity generated by somatic recombination.

Their functions divide along lineage lines. CD4-positive helper T cells coordinate the response, secreting cytokines that activate B cells, macrophages and cytotoxic cells. CD8-positive cytotoxic T cells kill directly, recognising and destroying infected or malignant cells displaying foreign peptide on MHC class I. Regulatory T cells restrain the response and maintain tolerance, and their loss produces autoimmunity. Because these populations differ functionally but look identical down a microscope, distinguishing them requires surface phenotype — which is what immunophenotyping provides.

What is immunophenotyping?

Immunophenotyping identifies and characterises cell populations by the antigens they display. Cells are labelled with antibodies against specific surface or intracellular proteins, each antibody carrying a distinct fluorophore, and the resulting fluorescence pattern assigns each cell to a population.

The power of the approach is combinatorial. Individually, most markers are uninformative — CD25 appears on activated conventional T cells and on regulatory T cells alike, and CD45 is on all leukocytes. Read together, marker combinations resolve populations that no single antigen can: CD3-positive with CD4-positive and CD25-high with FOXP3-positive is a regulatory T cell, while the same cell without FOXP3 is simply an activated helper cell. Panel design is therefore the substance of the technique.

Immunophenotyping by flow cytometry

Flow cytometry passes cells in single file through one or more laser beams, recording light scatter and fluorescence emission for each cell individually. Forward and side scatter report size and internal complexity, while fluorescence reports which labelled antibodies are bound. Modern instruments resolve well over a dozen parameters simultaneously, which is what makes multi-marker subsetting practical.

Where populations must be physically recovered rather than merely counted, fluorescence-activated cell sorting diverts cells of a chosen phenotype into collection tubes. Sorting is performed on the basis of scatter and fluorescence signals, not on colour in any visual sense, and yields viable populations suitable for culture, stimulation or sequencing. Magnetic bead separation offers a cheaper alternative when only one or two markers are needed and high purity is not essential.

Two practical points determine whether the data are interpretable. Compensation must be set correctly, because fluorophore emission spectra overlap and uncorrected spillover creates artefactual double-positive populations. And gating strategy must be defined in advance — debris and doublets excluded, viability assessed, then the pan-T gate applied before subsetting — since post hoc gating to a desired answer is the most common source of irreproducible flow data.

T cell subsets and their markers

The tables below give the markers characterising each major subset, with the function each marker serves. Markers recur across subsets, which is the point: identity is the pattern, not any one entry.

Naive T cells

Naive T cells have completed thymic development but not yet encountered their cognate antigen. They circulate between blood and secondary lymphoid organs, and their marker profile reflects that trafficking requirement — high CD62L and CCR7 for lymph node entry, and the CD45RA isoform.

Activated T cells

Activation upregulates a characteristic set of surface proteins, and their timing differs usefully. CD69 appears within hours and is the earliest conventional activation marker. CD25, the IL-2 receptor alpha chain, follows over the first day or two and supports clonal expansion. HLA-DR appears later and persists, indicating sustained activation. CD154, also called CD40 ligand, is transiently expressed and mediates help to B cells. Choosing which to stain therefore depends on the timepoint being interrogated.

Effector T cells

Effector cells have differentiated to carry out function — cytokine secretion, B cell help, or direct killing. They characteristically lose CD62L and CCR7, gaining tissue-homing receptors instead, which is why an effector population is defined as much by what it has lost as by what it has gained.

CD4-positive helper T cells

CD4 is the co-receptor for MHC class II, and CD4-positive cells coordinate rather than execute. Their subsets are distinguished by transcription factors and secreted cytokines rather than by surface markers alone, which is covered in the next section.

CD8-positive cytotoxic T cells

CD8 is the co-receptor for MHC class I, present on nearly all nucleated cells, which is what allows cytotoxic T cells to survey the whole body for intracellular infection and malignant change. Killing proceeds through perforin and granzyme release and through Fas ligand engagement.

Memory T cells

A fraction of responding cells persists after antigen clearance as memory, providing faster and larger secondary responses. Memory cells carry CD45RO in place of CD45RA, and CD62L separates them further: central memory cells retain CD62L and CCR7 and recirculate through lymph nodes, while effector memory cells lack them and patrol peripheral tissue.

Gamma delta T cells

Gamma delta T cells carry a receptor built from gamma and delta chains rather than alpha and beta. They are largely MHC-independent, recognising phosphoantigens and stress-induced ligands, respond rapidly, and are enriched in epithelial tissue. Crucially for panel design, most are neither CD4 nor CD8 positive, so a panel gating only on those co-receptors will discard them — identification requires a gamma delta TCR antibody.

Helper T cell subsets

CD4-positive helper cells differentiate into functionally distinct lineages depending on the cytokine environment at activation. Each lineage is defined by a master transcription factor and a signature cytokine, and it is that pairing rather than any surface marker that identifies it.

A clarification is needed here, because this is frequently misstated. Th0 is not a helper subset. The term refers to an uncommitted precursor state before lineage decisions are made, and by definition it lacks a master transcription factor. In particular, T-bet is the Th1 transcription factor, not a Th0 marker — assigning it to Th0 confuses a committed lineage with the undifferentiated state it arises from. The genuinely established helper lineages are Th1, Th2, Th17 and Tfh, with regulatory T cells as a distinct CD4-positive lineage that suppresses rather than helps.

Practically, identifying these subsets requires intracellular staining. Transcription factors are nuclear and cytokines are secreted, so both need fixation and permeabilisation, and cytokine detection usually needs brief restimulation with a secretion inhibitor. Regulatory T cells are the common case: surface CD3, CD4 and high CD25, combined with intracellular FOXP3 and typically low CD127.

Designing a T cell panel

Panels are built outwards from the gate rather than assembled from a marker wish list. A defensible sequence:

• Viability and exclusion first. A viability dye plus scatter-based doublet exclusion, before any phenotypic gate. Dead cells bind antibody non-specifically and generate false positives across every channel.
• Pan-leukocyte and pan-T gates. CD45 to identify leukocytes where the sample is tissue rather than blood, then CD3 for T cells.
• Lineage split. CD4 and CD8. Include a gamma delta TCR antibody if those cells are of interest, since they fall outside both.
• Differentiation state. CD45RA with CD62L or CCR7 resolves naive, central memory, effector memory and terminally differentiated compartments.
• Activation and regulation. CD69, CD25 or HLA-DR according to the timepoint; FOXP3 and CD127 for regulatory cells.
• Assign fluorophores by abundance. Put the brightest fluorophores on the dimmest or most sparsely expressed antigens, and keep highly expressed markers such as CD3 on dimmer channels. This single decision affects resolution more than anything else in the panel.
• Include the right controls. Single-stain compensation controls for every fluorophore, an unstained sample, and isotype or fluorescence-minus-one controls to set gates defensibly.

Applications

Immunophenotyping is used wherever the composition of an immune compartment matters rather than its bulk size.

• Haematological malignancy. Classification of leukaemias and lymphomas rests substantially on immunophenotype, which identifies lineage and maturation stage and detects clonal populations by aberrant marker combinations.
• Immunodeficiency workup. Enumerating T, B and NK compartments distinguishes the major categories of primary immunodeficiency and guides genetic testing.
• Monitoring treatment. Tracking subset composition over time reports on disease progression and therapeutic effect, and is routine in HIV care through CD4 counts.
• Vaccine immunogenicity. Measuring antigen-specific T cell activation and expansion after vaccination indicates whether a cellular response was induced, not merely an antibody one.
• Immunotherapy. Checkpoint inhibitor and CAR-T programmes depend on phenotyping to track persistence, exhaustion and differentiation state of infused or reactivated cells.
• Immune ageing. The naive-to-memory ratio shifts with age, and immunophenotyping quantifies that change and its association with infection susceptibility.

Immunophenotyping in T cell immunodeficiency

Where T cell function is impaired, immunophenotyping establishes which compartments are missing or abnormal, and that pattern narrows the differential before sequencing confirms the cause. The examples below are the ones most often encountered.

Two corrections are worth stating plainly, because both errors circulate widely. SCID is not caused by defects in the IL-12 receptor beta chain — that gene underlies susceptibility to mycobacterial and salmonella infection, a distinct and much narrower phenotype. And DiGeorge syndrome arises from the 22q11.2 deletion involving TBX1, not TBX21; the latter encodes T-bet, the Th1 transcription factor discussed above, and the similar names are the likely source of the confusion.

Chronic granulomatous disease is also sometimes listed among T cell immunodeficiencies. It results from defective NADPH oxidase and is a disorder of phagocyte killing, so while it appears in an immunodeficiency workup it is not a T cell defect and would not present with an abnormal T cell phenotype. Diagnosis of any of these requires specialist assessment, and nothing here is clinical advice.

Frequently asked questions